Insilico has at least 28 AI-developed drugs, nearly half in
Insilico利用生成式AI工具已开发出至少28款药物，其中近一半已进入临床阶段。
English original
Insilico has developed at least 28 drugs using generative AI tools, with nearly half already at a clinical stage, Alex Zhavoronkov, founder and CEO of Insilico, told CNBC.
对CNBC表示
A
亚历克斯·扎沃龙科夫Insilico Medicine · 创始人
原始出处
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market报道摘要
Hong Kong-listed Insilico Medicine has reached a deal with U.S. pharma giant Eli Lilly for AI-discovered drugs. The two companies have worked together since 2023. Insilico's CEO, Alex Zhavoronkov, ...
CNBC